3/1
02:44 pm
auph
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
Low
Report
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
2/23
12:09 pm
auph
Rating for AUPH
Low
Report
Rating for AUPH
2/16
11:11 am
auph
Rating for AUPH
Low
Report
Rating for AUPH
2/16
11:11 am
auph
Rating for AUPH
Low
Report
Rating for AUPH